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CORRECTION OPEN
Correction: Widespread white matter microstructural
abnormalities in bipolar disorder: evidence from
mega- and meta-analyses across 3033 individuals
Pauline Favre 1,2, Melissa Pauling1,2, Jacques Stout1, Franz Hozer1,2,3,4, Samuel Sarrazin1,2,5,6, Christoph Abé7, Martin Alda 8,
Clara Alloza 9,10, Silvia Alonso-Lana11,12, Ole A. Andreassen13,14, Bernhard T. Baune15,16, Francesco Benedetti17,18,
Geraldo F. Busatto19,20, Erick J. Canales-Rodríguez11, Xavier Caseras21, Tiffany Moukbel Chaim-Avancini19,20, Christopher R. K. Ching22,23,
Udo Dannlowski16, Michael Deppe24, Lisa T. Eyler25,26, Mar Fatjo-Vilas27,28, Sonya F. Foley29, Dominik Grotegerd16, Tomas Hajek8,
Unn K. Haukvik13,14, Fleur M. Howells30,31, Neda Jahanshad22, Harald Kugel 32, Trine V. Lagerberg13,14, Stephen M. Lawrie 33,
Julia O. Linke34,35, Andrew McIntosh 33,36, Elisa M. T. Melloni37, Philip B. Mitchell38,39, Mircea Polosan40, Edith Pomarol-Clotet27,28,
Jonathan Repple16, Gloria Roberts38,39, Annerine Roos41, Pedro G. P. Rosa19,20, Raymond Salvador28,29, Salvador Sarró28,29,
Peter R. Schofield 42,43, Mauricio H. Serpa17,18, Kang Sim44,45,46, Dan J. Stein 41, Jess E. Sussmann33, Henk S. Temmingh30,47,
Paul M. Thompson23, Norma Verdolini27,28,48, Eduard Vieta28,48, Michele Wessa34, Heather C. Whalley 34, Marcus V. Zanetti18,19,49,
Marion Leboyer1,50,51, Jean-François Mangin1, Chantal Henry52, Edouard Duchesnay1 and Josselin Houenou 1,2,50,51 for the
ENIGMA Bipolar Disorder Working Group
Neuropsychopharmacology (2019) 44:2298; https://doi.org/10.1038/s41386-019-0521-6
Correction to: Neuropsychopharmacology https://doi.org/10.1038/
s41386-019-0485-6, published online 21 August 2019.
This Article was originally published under NPG's License to
Publish, but has now been made available under a [CC BY 4.0]
license. The PDF and HTML versions of the Article have been
modified accordingly.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing, adaptation,
distribution and reproduction in anymediumor format, as long as you give appropriate
credit to the original author(s) and the source, provide a link to the Creative Commons
license, and indicate if changes were made. The images or other third party material in
this article are included in the article’s Creative Commons license, unless indicated
otherwise in a credit line to the material. If material is not included in the article’s
Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly
from the copyright holder. To view a copy of this license, visit http://creativecommons.
org/licenses/by/4.0/.
© The Author(s) 2019
Published online: 16 September 2019
1Neurospin, CEA, Université Paris-Saclay, Gif-sur-Yvette, France; 2INSERM Unit U955, Team 15, “Translational Psychiatry”, Créteil, France; 3Assistance Publique-Hôpitaux de Paris (AP-
HP), Corentin-Celton Hospital, Department of Psychiatry, Issy-les-Moulineaux, France; 4Paris Descartes University, PRES Sorbonne Paris Cité, Paris, France; 5Pôle de psychiatrie, DHU
PePSY, Hôpitaux Universitaires Mondor, Créteil, France; 6Bipol Falret, Fondation Falret, St Ouen, France; 7Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden;
8Department of Psychiatry, Dalhousie University, Halifax, Canada; 9Division of Psychiatry, University of Edinburgh, Edinburgh, UK; 10Department of Child and Adolescent Psychiatry,
IISGM, Hospital General Universitario Gregorio Marañón, Madrid, Spain; 11FIDMAG Research Foundation, Barcelona, Spain; 12CIBERSAM, Barcelona, Spain; 13Department of Mental
Health and Addiction, University of Oslo, Oslo, Norway; 14NORMENT K.G. Jebsen Centre for Psychosis Research, Oslo University Hospital, Oslo, Norway; 15Department of Psychiatry,
University of Melbourne, Melbourne, Australia; 16Department of Psychiatry, University of Münster, Münster, Germany; 17Division of Neuroscience, San Raffaele Scientific Institute,
Milano, Italy; 18University Vita-Salute San Raffaele, Milano, Italy; 19Laboratory of Psychiatric Neuroimaging (LIM-21), Departamento e Instituto de Psiquiatria, Hospital das Clinicas
HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil; 20Centrer for Interdisciplinary Research on Applied Neurosciences (NAPNA), University of São
Paulo, São Paulo, Brazil; 21MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK; 22Interdepartmental Neuroscience Program, University of
California, Los Angeles, CA, USA; 23Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of
Southern California, Marina del Rey, Los Angeles, CA, USA; 24University of Münster, Department of Neurology, Münster, Germany; 25Department of Psychiatry, University of
California San Diego, La Jolla, CA, USA; 26Mental Illness Research Education and Clinical Center, VA San Diego Healthcare System, La Jolla, CA, USA; 27FIDMAG Research Foundation,
Barcelona, Spain; 28CIBERSAM, Barcelona, Spain; 29Cardiff University Brain Research Imaging Centre (CUBRIC), Cardiff University, Cardiff, UK; 30Department of Psychiatry and Mental
Health, University of Cape Town, Cape Town, South Africa; 31Neuroscience Institute, University of Cape Town, Cape Town, South Africa; 32University of Muenster, Institute of Clinical
Radiology, Münster, Germany; 33Department of Psychiatry, Royal Edinburgh Hospital, Edinburgh, UK; 34Department of Clinical Psychology and Neuropsychology, Johannes
Gutenberg-Universität Mainz, Mainz, Germany; 35Emotion and Development Branch, National Institute of Mental Health, Bethesda, MD, USA; 36Center for Cognitive Ageing and
Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK; 37Psychiatry and Clinical Psychobiology, Division of Neuroscience, Scientific Institute and University Vita-Salute
San Raffaele, Milano, Italy; 38School of Psychiatry, University of New South Wales, Sydney, Australia; 39Black Dog Institute, Sydney, Sydney, Australia; 40Univ. Grenoble Alpes, Inserm,
U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Grenoble, France; 41Dept of Psychiatry, SAMRC Unit on Risk & Resilience in Mental Disorders, University of Cape Town,
Cape Town, South Africa; 42Neuroscience Research Australia, Sydney, Australia; 43School of Medical Sciences, University of New South Wales, Sydney, Australia; 44West Region,
Institute of Mental Health, Singapore, Singapore; 45Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; 46Lee Kong Chian School of Medicine,
Nanyang Technological University, Singapore, Singapore; 47Valkenberg Hospital, Cape Town, South Africa; 48Institute of Neuroscience, Hospital Clinic, University of Barcelona,
IDIBAPS, Barcelona, Spain; 49Hospital Sírio-Libanês, São Paulo, Brazil; 50Assistance Publique-Hôpitaux de Paris (AP-HP), CHU Mondor, Psychiatry Department, Créteil, France;
51Faculté de Médecine, Université Paris Est Créteil, Créteil, France and 52Institut Pasteur, Unité Perception et Mémoire, Paris, France
Correspondence: Pauline Favre (pauline@favre-univ.fr)
www.nature.com/npp
© The Author(s) 2019
1
2
3
4
5
6
7
8
9
0
()
;,:
